Daniel Cochran, MD
Neurological Surgery · Norman, OKNPI 1528195252
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $20,674 of the $24,809 with a category attached, or 83.3%. Medtronic accounts for 92.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $15,734 and has fallen 97.2% since, to $443 in 2025.
Across 85 payments — averaging $291.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$23K
- Alphatec Spine, Inc$1K
- Chiesi USA, Inc.$138
- Organogenesis Inc.$106
- Intrinsic Therapeutics$74
- Boston Scientific$72
- plus $335 from 14 others
What the payments were for
- Consulting fees$20,67483%
- Travel & lodging$2,1629%
- Food & beverage$1,9748%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 56 | $23,007 |
| Alphatec Spine, Inc | 5 | $1,077 |
| Chiesi USA, Inc. | 2 | $138 |
| Organogenesis Inc. | 1 | $106 |
| Intrinsic Therapeutics | 1 | $74 |
| Boston Scientific | 3 | $72 |
| Portola Pharmaceuticals, LLC | 3 | $57 |
| Orthofix Medical, Inc. | 2 | $45 |
| Kahtnu Surgical, Inc. | 1 | $42 |
| Livanova USA, Inc. | 1 | $27 |
| Innovation Technologies Inc | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $22 |
| Si-bone, Inc. | 1 | $19 |
| Olympus America Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Nevro Corp. | 1 | $15 |
| Deroyal Industries, Inc. | 1 | $15 |
| Stryker | 1 | $14 |
| Baudax Bio Inc. | 1 | $14 |
| Arteriocyte Medical Systems, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CD HORIZON$14,703
- Other - Miscellaneous$854
- MazorX - Renaissance$211
- INCEPTIV$174
- CLEVIPREX$122
- MULTIPLE$114
- PuraPly$106
How this compares
$24,809 in reported general payments places this provider in the 80th percentile of 80 neurological surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 118 | $1,425 |
| Methocarbamol | 57 | $960 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 44 | $743 |
| Baclofen | 34 | $407 |
| Gabapentin | 29 | $288 |
| Methylprednisolone | 25 | $185 |
| Levetiracetam | 17 | $180 |
| Meloxicam | 12 | $114 |
| Tamsulosin Hcl | 11 | $108 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Norman
- Shon CookNorman$11K
- Kimball PrattNorman$6K
- Jeremy PhelpsNorman$866
- Brian SnellOklahoma City$3.7M
- Fadi NasrOklahoma City$1.6M
- Clinton BairdTulsa$621K
- Robert TibbsOklahoma City$537K
- Michael HahnOklahoma City$267K
- Christopher BarryEdmond$181K
- Isaac KarikariOklahoma City$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.